PWC analysis of US tariffs on the global medical devices, life science and pharmaceutical industry

The recent imposition and pausing of tariffs by the US has created uncertainties globally. This has presented medical devices companies with both threats and opportunities. It is highly likely that member countries will all be affected by the changes. This can be within increased cost associated with operations, compliance and supply chains. Or increased buying costs for businesses. PWC has published an analysis on the impact of tariffs for the medical devices, life science and pharmaceutical industries. This provides some insight for both medical devices businesses and consumers for potential forward planning.

Link: https://www.pwc.com/us/en/services/tax/library/tariff-industry-analysis-pharma-life-science-and-medical-device.html